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Biomechanical signaling within the developing
zebraﬁsh heart attunes endocardial growth
to myocardial chamber dimensions
Dorothee Bornhorst 1,2, Peng Xia 3, Hiroyuki Nakajima 4, Chaitanya Dingare 5, Wiebke Herzog 6,7,
Virginie Lecaudey 5, Naoki Mochizuki 4,8, Carl-Philipp Heisenberg 3, Deborah Yelon9 &
Salim Abdelilah-Seyfried 1,2
Intra-organ communication guides morphogenetic processes that are essential for an organ
to carry out complex physiological functions. In the heart, the growth of the myocardium is
tightly coupled to that of the endocardium, a specialized endothelial tissue that lines its
interior. Several molecular pathways have been implicated in the communication between
these tissues including secreted factors, components of the extracellular matrix, or proteins
involved in cell-cell communication. Yet, it is unknown how the growth of the endocardium is
coordinated with that of the myocardium. Here, we show that an increased expansion of the
myocardial atrial chamber volume generates higher junctional forces within endocardial cells.
This leads to biomechanical signaling involving VE-cadherin, triggering nuclear localization of
the Hippo pathway transcriptional regulator Yap1 and endocardial proliferation. Our work
suggests that the growth of the endocardium results from myocardial chamber volume
expansion and ends when the tension on the tissue is relaxed.
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The growth and morphogenesis of organs requires somemeans of intra-organ communication between its differenttissues. In the heart, biochemical signaling of secreted
factors such as Wnts, BMPs, FGFs, or components of the extra-
cellular matrix and cell–cell communication via the Notch,
Neuregulin/ErbB2, or Ephrin signaling pathways1–3 are involved.
Yet, it is unknown which modes of communication coordinate
the growth of the endocardium with that of the myocardium. In
zebraﬁsh, during the process of cardiac ballooning at 30–54 hours
post fertilization (hpf), endocardial chambers grow by prolifera-
tion with neither accretion of cells from external sources, nor
from cellular intermingling over the chamber boundary at the
atrioventricular canal4. In striking contrast, the myocardium
grows mostly through an accretion of cells to the chamber
poles5–8 and due to cell size increases9,10. Here, we use two dif-
ferent genetic conditions (loss of Nkx2.5 or increase in Wnt8a
expression) that cause an exaggerated expansion of myocardial
atrial chamber dimensions. Comparing these two extreme con-
ditions to WT reveals that an increased expansion of myocardial
atrial chamber dimensions is compensated by increased endo-
cardial proliferation and cell numbers. We ﬁnd that an increased
expansion of the atrial chamber volume generates higher junc-
tional forces within endocardial cell junctions which are trans-
duced by the endothelial-speciﬁc adherens junction protein
Cadherin-5 (VE-cadherin) to activate Hippo pathway transcrip-
tional regulator Yap1-dependent endocardial proliferation.
Results
Endocardial cell proliferation increases in larger atrial cham-
bers. To examine whether changes in the dimensions of the
myocardial chambers affect endocardial cell numbers, we ana-
lyzed two well-established genetic conditions that cause changes
in their relative dimensions. Upon heat shock at 24 hpf, the atrial
myocardium of the zebraﬁsh transgenic line Tg(hsp70l:wnt8a-
GFP)w34 (referred to as hs:wnt8a) undergoes a massive increase in
volume and cell numbers as determined at 52 hpf, whereas the
ventricular chamber decreases in size11. We also employed the
nkx2.5vu179 mutant, which causes a comparable myocardial
phenotype12. In both genetic conditions, atrial chamber growth
involves increases in myocardial cell numbers while numbers of
ventricular cardiomyocytes are reduced (Supplementary
Fig. 1)11,13,14. We reasoned that these two different genetic con-
ditions would be good tools to study the response of the endo-
cardium to this mode of myocardial atrial chamber expansion.
We found that under these two genetic conditions, the
dimensions of the endocardial chambers underwent comparable
changes at 52 hpf, which is the stage when relative chamber
dimensions are established. Compared with WT, the over-
expression of Wnt8a resulted in a relative shift of endocardial
chamber dimensions with an enlarged atrium containing higher
endocardial cell numbers and a smaller ventricle (Fig. 1a, b, g). To
clearly identify chamber identities, the transgenic reporter line Tg
(ﬂt1:YFP)hu4624 which mainly marks ventricular endocardial
cells15 was counter-stained with the myocardial atrial marker
anti-Myosin heavy chain 6 (Myh6) which includes cells at the
atrioventricular canal where Myh6-positive cardiomyocytes form
a sharp boundary (Fig. 1d, e). Similarly, relative shifts in chamber
dimensions with an increase of atrial endocardial cell numbers
occurred in nkx2.5vu179 mutants (Fig. 1c, g)13,14 which are
phenotypically similar to the antisense oligonucleotide morpho-
lino (MO)-mediated knock down of Nkx2.5/Nkx2.713. The latter
condition resulted in a smaller endocardial ventricular chamber,
as indicated by the expression of Tg(ﬂt1:YFP)hu4624 (Fig. 1f).
These endocardial-speciﬁc changes mirrored those that occur
within the myocardium under these conditions (Supplementary
Fig. 1)11–13.
One explanation for the increased number of endocardial cells
might be their proliferation. We found that the numbers of atrial
and ventricular endocardial cells were identical between all
genetic conditions analyzed at 30 hpf (Fig. 2a). This indicates that
the sizes of endocardial progenitor cell pools were not altered.
Hence the respective proliferation rates were examined by
injections of EdU into the circulatory system at 30 hpf and
analyzed its incorporation within endocardial cells at 52 hpf
(Fig. 2b). As a result, the rate of endocardial cell proliferation
increased signiﬁcantly within the atrium but not the ventricle
compared to WT (Fig. 2c–f, s) upon Wnt8a overexpression
(Fig. 2g–j, s), in nkx2.5vu179 mutants (Fig. 2k–n, s), or upon knock
down of Nkx2.5/Nkx2.7 (Fig. 2o–r, s). In contrast, no increase in
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Fig. 1 Overexpression of Wnt8a or loss of Nkx2.5 causes a shift in
endocardial chamber proportions. a–c Reconstruction of confocal z-stacks
show the endothelial-speciﬁc transgenic reporter lines Tg(kdrl:EGFP)s843 or
Tg(ﬂi1a:nEGFP)y7 (green), Phalloidin 568-stained Actin (red) and anti-Myh6
labeling of the myocardial atrial chamber (magenta). Compared to (a) WT,
(b) overexpression of Wnt8a, or (c) the nkx2.5vu179 mutation, causes a
relative shift of endocardial chamber dimensions. d–f Reconstructions of
confocal z-stacks shows that the arterial endothelial transgene Tg(ﬂt1:YFP)
hu4624 marks the ventricular chamber whereas the myocardial atrial marker
anti-Myh6 labels the atrial chamber. Compared to (d) WT, (e)
overexpression of Wnt8a, or (f) loss of Nkx2.5/Nkx2.7 results in relative
shifts of chamber dimensions as indicated by the ventricular-speciﬁc
expression of Tg(ﬂt1:YFP)hu4624 within the endocardium. A, atrium; V,
ventricle. Scale bars, 30 μm. g Quantiﬁcations of endocardial cell numbers
in WT (kdrl:GFP n= 11 hearts, ﬂi1a:nEGFP n= 27 hearts), Tg(hsp70l:wnt8a-
GFP)w34 (n= 8 hearts), or nkx2.5vu179 mutants (n= 27 hearts) reveal that
atrial endocardial cell numbers are signiﬁcantly increased and ventricular
endocardial cell numbers are signiﬁcantly reduced compared to WT. Mean
values ± SD are shown. Two-way ANOVA was used to compare each
condition with its WT control in each individual chamber (****p < 0.0001)
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Fig. 2 Atrial endocardial cell proliferation is increased upon Wnt8a overexpression or in nkx2.5vu179 mutants. a Quantiﬁcations of endocardial cell numbers
at 30 hpf reveals that there is no increase of atrial endocardial cells in Tg(hsp70l:wnt8a-GFP)w34 (n= 9 hearts), or nkx2.5vu179 mutant embryos (n= 10
hearts) compared with WT (kdrl:GFP n= 10 hearts, ﬂi1a:nEGFP n= 9 hearts) at this stage. At the later heart ballooning stage (52 hpf), a signiﬁcant increase
of endocardial atrial cell numbers has occurred upon Wnt8a overexpression [Tg(hsp70l:wnt8a-GFP)w34 (n= 8 hearts)] or in nkx2.5vu179 mutants (n= 27
hearts) compared to WT (kdrl:GFP n= 11 hearts, ﬂi1a:nEGFP n= 27 hearts). Mean values ± SD are shown. Two-way ANOVA was used to compare each
condition with its WT control in each individual chamber (ns: not signiﬁcant,****p < 0.0001). b Schematic model of the EdU assay used. WT and Tg(hsp70l:
wnt8a-GFP)w34 transgenic embryos were heat shocked at 24 hpf. Embryos of all genotypes were injected with EdU into the circulatory system at 30 hpf and
analyzed at 52 hpf. c, g, k, o Reconstructions of confocal z-stacks showing representative hearts at 52 hpf of (c) WT, (g) upon Wnt8a overexpression,
(k) in nkx2.5vu179 mutants, or (o) in nkx2.5/nkx2.7 double morphants. Endocardial tissue is marked by Tg(kdrl:EGFP)s843 or Tg(ﬂi1a:nEGFP)y7 reporters
(white) and proliferative cells are marked by EdU incorporation (red). A, atrium; V, ventricle. Scale bars, 30 μm. d–f, h–j, l–n, p–r Shown are magniﬁcations
of insets (yellow boxes) with kdrl:GFP or ﬂi1a:nEGFP/EdU double positive cells (yellow arrowhead). Single channel with kdrl:GFP or ﬂi1a:nEGFP (d, h, l, p),
EdU incorporation (e, i, m, q) and the merge of both channels (f, j, n, r). Scale bars, 10 μm. s Quantiﬁcations of the share of EdU+ atrial or ventricular
endocardial cells relative to the total number of endocardial cells within the respective cardiac chamber in WT (kdrl:GFP n= 8 hearts, ﬂi1a:nEGFP n= 13
hearts), upon Wnt8a overexpression (n= 9 hearts), nkx2.5vu179 mutants (n= 8 hearts), or nkx2.5/nkx2.7 double morphants (n= 8 hearts). Upon Wnt8a
overexpression or loss of Nkx2.5 or Nkx2.5/Nkx2.7, proliferation signiﬁcantly increases in the developing atrial endocardium. Mean values ± SD are shown.
Two-way ANOVA was used to compare each condition with its WT control in each individual chamber (ns: not signiﬁcant; ***p < 0.001, ****p < 0.0001)
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cell proliferation was observed upon Wnt8a overexpression
within the myocardium despite strong EdU-labeling within some
extra-cardiac tissues (Supplementary Fig. 2). This is similar to
what has been reported for nkx2.5vu179 mutants or nkx2.5/nkx2.7
double morphants12,13. Hence, the increases in atrial endocardial
cell numbers correspond with more proliferation.
Endocardial cell sizes are unaltered in enlarged atrial cham-
bers. Using an in vivo multi-color mosaic labeling technique16
and morphometric measurements of immunolabeled hearts, we
discovered that increased Wnt8a expression or loss of Nkx2.5
caused striking increases in the size of atrial cells within the
myocardium (Supplementary Fig. 3 a–f; Supplementary Movies
1,2). We also used an alternative measurement and determined
inter-nuclear distances in WT and upon Wnt8a overexpression,
which provided the same result (Supplementary Fig. 3g). We
wondered whether endocardial cell sizes were equally affected by
the strong expansion of cardiac chamber dimensions. To quantify
endocardial cell sizes, we measured at least 20 endocardial inter-
nuclear distances per heart using the endocardial marker lines Tg
(kdrl:EGFP)s843 or Tg(ﬂi1a:nEGFP)y7 at 52 hpf. Although atrial
endocardial chambers were expanded under these conditions,
Wnt8a overexpression (Fig. 3b, e–g) or loss of Nkx2.5 (Fig. 3d–g)
did not result in signiﬁcant changes in inter-nuclear distances or
endocardial cell densities within the atrial endocardium com-
pared to WT (Fig. 3a, c, e–g). Thus cell size increases are not
responsible for the expansion of the atrial endocardial chamber in
these two conditions.
Endocardial cell junctional tension increases within a larger
atrium. Our observations suggested that myocardial chamber
dimensions inﬂuence the proliferation of endocardial cells. This
hinted at some form of intra-organ communication between the
myocardium and endocardium. Cells within the endocardium
and myocardium are separated by a layer of extracellular matrix
(cardiac jelly)2 which can propagate mechanical tension17,18. We
hypothesized that when the size of endocardial cells remains
constant, tensile forces on their cell junctions rise through the
expansion of atrial chambers that occurs upon Wnt8a over-
expression or loss of Nkx2.5/Nkx2.7.
To address this issue, we adapted an ultraviolet (UV)-laser
dissection set-up19 to measure cell junctional forces within the
zebraﬁsh endocardium. The transgenic reporter line Tg(act2:
myl12.1-EGFP)e2212, which labels the non-muscle myosin II
cytoskeleton, distinctly marks the sub-membranous compartment
of endocardial cells20 which is distinct from the sarcomeric
myocardium (Supplementary Movie 3). This permitted us to
direct the UV-laser at cell junctions to measure the recoil of
endocardial cell junctions upon dissection. To assess whether cell
junction tensile forces differed between blood ﬂow-parallel and
cell junctions with an orientation perpendicular to the direction
of blood ﬂow, we performed measurements of recoil velocities in
WT. This revealed no signiﬁcant differences in initial recoil
velocities between these different membrane compartments
(Supplementary Fig. 4). To compare cell junctional forces, we
targeted only the shorter perpendicular cell junction compart-
ments of endocardial cells (red membrane compartments in
Fig. 4a, b) and performed only one dissection per endocardium
within a cell positioned near the inﬂow tract region to avoid
tissue-relaxation upon neighboring cells (Fig. 4a, b).
To assess junctional tensile forces while the chamber expansion
process was still ongoing at 40 hpf, we anaesthetized embryos
and paused their heart beat with tricaine, which does not affect
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Fig. 3 Endocardial cell sizes are not altered upon atrial chamber expansion. a–d Reconstructions of confocal z-stacks of representative hearts at 52 hpf of
(a) WT, (b) upon Wnt8a overexpression, (c) WT, or (d) in nkx2.5vu179 mutants. Endocardial GFP expression of Tg(kdrl:EGFP)s843 or Tg(ﬂi1a:nEGFP)y7 is
inverted in black/white. Endocardial inter-nuclear distances are indicated by arrows and a dotted line indicates the outline of the endocardium. Scale bars,
30 µm. e Quantiﬁcations of endocardial inter-nuclear distances reveal no signiﬁcant differences between WT (kdrl:GFP n= 6 hearts, ﬂi1a:nEGFP n= 9
hearts), upon Wnt8a overexpression (n= 6 hearts), or in nkx2.5vu179 mutants (n= 9 hearts). Each dot represents one heart with an average of at least 20
length measurements within the endocardial atrium. f Quantiﬁcations of the atrial endocardial surface area reveals a signiﬁcant increase upon Wnt8a
overexpression (n= 7 hearts) or loss of Nkx2.5 (n= 10 hearts) compared to WT hearts (kdrl:GFP n= 12 hearts, ﬂi1a:nEGFP n= 12 hearts).
g Quantiﬁcations of the ratio of endocardial cell numbers relative to total atrial chamber area indicates no signiﬁcant differences between WT (kdrl:GFP
n= 11 hearts, ﬂi1a:nEGFP n= 12 hearts), upon Wnt8a overexpression (n= 8 hearts), or in nkx2.5vu179 mutants (n= 10 hearts). e–g Mean values ± SD are
shown. One-way ANOVA was used to compare each condition with its WT control (ns: not signiﬁcant, ****p < 0.0001)
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non-muscle myosin II. Time lapse movies of Tg(act2:myl12.1-
EGFP)e2212 localization after the cell junction cuts were recorded
for a period of 15.6 s at 0.2 second intervals (Fig. 4c–e;
Supplementary Movies 4-6). Upon Wnt8a overexpression, tensile
forces in endocardial cell junctions are higher compared with WT
(Fig. 4c), as indicated by a greater width of myosin recoil at 0.4 s
after laser dissection (Fig. 4d). Based on slope measurements of
the kymographs (see Materials and Methods), we determined the
initial recoil velocities (μm per sec) in WT (Fig. 4c), upon Wnt8a
overexpression (Fig. 4d), or upon loss of Nkx2.5/Nkx2.7 (Fig. 4e).
These analyses revealed that endocardial cell junctions are under
higher tensile forces while chamber dimensions are expanding
(Fig. 4f). Our ﬁndings imply that the expanding dimensions of
atrial myocardial chambers cause stronger tensile forces upon cell
junctions within the endocardium. This ﬁnding suggested that in
response, endocardial cells may activate biomechanical signaling
pathways to regulate proliferation, which subsequently releases
tension within this tissue.
Cadherin-5 mediates endocardial proliferation during cham-
ber expansion. The sensing and transmission of force between
endothelial cells has been attributed to a mechanosensitive
complex that includes Cadherin-520–23. This endothelial-speciﬁc
adherens junction protein links the contractile acto-myosin
cytoskeleton to the cell membrane21,24. We wondered whether
Cadherin-5 plays a similar role within endocardium and exam-
ined whether a loss of Cadherin-5 would reduce endocardial cell
numbers upon the overexpression of Wnt8a or loss of Nkx2.5.
Since cadherin-5 mutants display a dysmorphic heart24 and lack
blood ﬂow, which would impact endocardial proliferation4 we
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Fig. 4 Endocardial tissue tension increases upon Wnt8a overexpression or loss of Nkx2.5/Nkx2.7. a, b Schematic model illustrating the endocardial region
in which the laser cuts were performed. Local laser cut (yellow arrow) of the subcortical actomyosin network within the shorter membrane compartment
(red) which is oriented perpendicular to the direction of intra-cardiac blood ﬂow at time point d0 causes an actomyosin recoil (d1). c–e Time lapse
sequences following a laser cut within the endocardium of 40 hpf embryos with the Tg(act2:myl12.1-EGFP)e2212 transgenic reporter that marks the
actomyosin network. Yellow arrows show the actomyosin recoil distance within 0.4ms upon laser dissection. Kymographs indicate the temporal recoil of
the actomyosin network along the membrane compartment where the laser cut was performed. The recoil of the open junction ends is visualized with the
ﬂuorescence intensity and the initial opening of the junction is marked by yellow arrowheads. d, e Time lapse analyses demonstrate a larger opening of the
junction (d1) and a faster recoil of the actomyosin network (yellow arrowheads in the kymograph) upon Wnt8a overexpression or loss of Nkx2.5/Nkx2.7
following laser cuts. Scale bars, 20 μm. f Comparison of initial recoil velocities (μm per sec) which are lower in WT (n= 37 hearts) compared with Wnt8a
overexpressing embryos (n= 28 hearts) or upon loss of Nkx2.5/Nkx2.7 (n= 11 hearts). Mean values ± SD are shown. One-way ANOVA was used to
compare each condition with WT (**p < 0.001)
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-12068-x ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:4113 | https://doi.org/10.1038/s41467-019-12068-x |www.nature.com/naturecommunications 5
used a well-established antisense oligonucleotide morpholino
(MO) against Cadherin-525 and selected those embryos with
blood ﬂow for further analyses. In support of an effect of
Cadherin-5 on cell proliferation during chamber expansion, we
found that atrial endocardial cell numbers were signiﬁcantly
reduced upon MO-mediated knock down of Cadherin-5 in
Wnt8a overexpressing or nkx2.5vu179 mutant but not in WT
hearts (Fig. 5a–f, j). Immunohistochemical analysis revealed that
Cadherin-5 was localized to endocardial cell junctions in Wnt8a
overexpressing or nkx2.5vu179 mutant embryos in a manner
similar to WT (Supplementary Fig. 5). Within the ventricular
endocardium, loss of Cadherin-5 caused diminished cell numbers
(Fig. 5k), which implies that Cadherin-5 also has a physiological
role in WT ventricular endocardial cell proliferation. In tune with
this ﬁnding, EdU-based proliferation assays revealed that a loss of
Cadherin-5 strongly diminished endocardial cell proliferation
under these different conditions (Supplementary Fig. 6). To test
whether this effect was due to a loss of cell junctional tensile
forces upon loss of Cadherin-5, we next performed UV-laser-
based force measurements (as described above) which showed
that a loss of Cadherin-5 has no effect (Supplementary Fig. 7;
Supplementary Movie 7). Taken together, these results suggest a
role for Cadherin-5 in force sensing/transmission but not in the
generation of cell junctional tensile forces within the endocardial
layer during the atrial chamber expansion process.
Yap1 is required during atrial endocardial chamber expansion.
Hippo signaling is involved in the control of tissue/organ size and
cell proliferation in a manner that is functionally dependent on
mechanical tension26. The Hippo pathway transcription factor
Yap1 plays a role in the control of endothelial cell proliferation in
response to blood ﬂow27,28. We used two independent means of
detecting Yap1 localization within the endocardium: First,
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Fig. 5 Loss of Cadherin-5 or Yap1 prevents endocardial cell number increases during atrial chamber expansion. a–i Reconstructions of confocal z-stacks of
zebraﬁsh hearts at 52 hpf expressing the endocardial reporter Tg(kdrl:EGFP)s843 or Tg(ﬂi1a:nEGFP)y7 (green) and immunolabeling against the myocardial
marker Alcam (magenta). j Quantiﬁcations of endocardial cell numbers at 52 hpf. b, j Upon Wnt8a overexpression (n= 7 hearts), atrial endocardial cell
numbers increase. c, j Similarly, in nkx2.5vu179 mutants (n= 27 hearts), endocardial cell numbers increase within the atrium. d, jMO-mediated knock down
of Cadherin-5 (Cdh5) (n= 7 hearts) does not cause a reduction of endocardial cell numbers within the atrium. e, j Loss of Cdh5 prevents increased atrial
endocardial cell numbers upon overexpression of Wnt8a (n= 8 hearts). f, j Loss of Cdh5 suppresses increased atrial endocardial cell numbers in
nkx2.5vu179 mutants (n= 19 hearts). g, j Loss of Yap1 via MO-mediated knock down (n= 14 hearts) or in yap1fu48 mutants (j, k) does not affect ventricular
or atrial endocardial cell numbers. h, j Knock down of Yap1 in Wnt8a overexpressing embryos normalizes ventricular and atrial endocardial cell numbers
(n= 8 hearts). i, j Loss of Yap1 rescues atrial endocardial cell numbers in nkx2.5vu179 mutants (n= 17 hearts). j A loss of Nkx2.5/Nkx2.7 in yap1fu48 mutants
also rescues atrial endocardial cell numbers. A atrium, V ventricle. Scale bars, 30 μm. j, k Quantiﬁcations of endocardial cell numbers in atrium and
ventricle. Mean values ± SD are shown. Two-way ANOVA was used to compare each condition with its WT control in each individual chamber (ns not
signiﬁcant; **p < 0.01;***p < 0.001; ****p < 0.0001)
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immunolabeling with a Yap1-speciﬁc antibody revealed Yap1-
positive endocardial cells within both heart chambers at 52 hpf
(Fig. 6a–d; Supplementary Fig. 8a–d) which was strongly reduced
in yap1 morphants (Fig. 6m, n). Second, a transgenic Yap-speciﬁc
reporter line, Tg(ﬂi1a:EGFP-YAP)ncv35, which also indicated
subcellular localization of Yap1 within endocardial cells (Sup-
plementary Fig. 8e–h). To elucidate whether Yap1 functionally
contributes to higher atrial endocardial cell numbers under
conditions of increased tissue tension, we performed a MO-
mediated knock down when Wnt8a was overexpressed or in
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Fig. 6 Yap1 nuclear localization within the atrial endocardium increases upon chamber expansion. a, e, i, m, o, q Reconstructions of confocal z-stacks of
zebraﬁsh hearts at 52 hpf expressing the endocardial reporters Tg(kdrl:EGFP)s843 or Tg(ﬂi1a:nEGFP)y7 (cyan) and immunolabeling against zebraﬁsh Yap1
(magenta). b, f, j, n, p, r Yap1 immunolabeling is inverted in black/white and endocardial cells which show co-localization with Yap1 labeling are marked
with red asterisks. A atrium, V ventricle. Scale bars, 30 μm. c, d, g, h, k, l Magniﬁcations of single confocal XY section planes (yellow box in a, e, i) are
shown in c, g, k and, in d, h, l, only Yap1 immunolabeling is shown. Endocardial cells, labeled by Tg(kdrl:EGFP)s843 or Tg(ﬂi1a:nEGFP)y7, that show co-
localization with Yap1 are indicated with an asterisk. Scale bars, 30 μm. s Quantiﬁcations of the share of Yap1-positive endocardial cells relative to the total
number of endocardial cells within the atrium. Upon Wnt8a overexpression (n= 6 hearts) or loss of Nkx2.5 (n= 3 hearts), the share of Yap1-positive
endocardial cell numbers signiﬁcantly increases within the developing atrial endocardium. Loss of Cadherin-5 (Cdh5) changes the share of Yap1-positive
endocardial cells among Wnt8a overexpressing (n= 9 hearts) or nkx2.5vu179 mutant embryos (n= 10 hearts) to WT levels. Knock down of Yap1 in all
conditions leads to a massive reduction of Yap1-positive endocardial cells within the atrium (yap1 MO: n= 11 hearts; yap1 MO+ hs:Wnt8a: n= 9 hearts;
yap1 MO+ nkx2.5vu179 mutant: n= 11 hearts). Mean values ± SD are shown. One-way ANOVA was used to compare each condition with its WT control
(ns not signiﬁcant, **p < 0.01;***p < 0.001; ****p < 0.0001)
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nkx2.5vu179 mutants (Fig. 5a–c, g–i, j, k). Although knock down
of Yap1 and yap1fu48 mutant endocardium and myocardium were
morphologically indistinguishable from WT and had blood ﬂow
(Fig. 5g, j, k; Supplementary Fig. 9), a knock down of Yap1 under
conditions of Wnt8a overexpression or loss of Nkx2.5, as well as
the effect of the yap1fu48 mutation upon loss of Nkx2.5/
Nkx2.7 signiﬁcantly reduced endocardial cell numbers (Fig. 5j, k)
and reduced atrial endocardial cell proliferation as indicated by
an EdU-incorporation assay (Supplementary Fig. 6). This
demonstrates an important role of Yap1 in endocardial cell
proliferation control when atrial chamber dimensions strongly
expand and generate tension on the tissue.
Cadherin-5 triggers Yap1 nuclear translocation within endo-
cardium. Increased tissue tension causes Yap1 translocation into
the nucleus, where it promotes the expression of genes involved
in cell proliferation28. E-Cadherin, for instance, was shown to
induce cell cycle reentry and sequential activation of Yap1
dependent on mechanical strain29. We used the Yap1-speciﬁc
antibody and assessed the ratio of endocardial cells with Yap1
nuclear localization relative to the entire population of atrial
endocardial cells (Fig. 6). Next, we analyzed the subcellular Yap1
localization under the two conditions with increased tissue ten-
sion. We observed a signiﬁcant increase in the share of atrial
endocardial cells with nuclear Yap1 localization when over-
expressing Wnt8a (Fig. 6e–h) or having lost Nkx2.5 (Fig. 6i–l)
compared to WT (Fig. 6a–d, s). This suggests that the increase in
proliferation in both genetic conditions is due to the localization
of Yap1 to the nucleus.
Given the important role of Cadherin-5 in force transmission
within the endocardial tissue layer, we also tested whether it was
required for Yap1 nuclear translocation upon overexpression of
Wnt8a or in nkx2.5vu179 mutants. Consistent with such a model,
loss of Cadherin-5 reduced the share of atrial endocardial cells
with a nuclear localization of Yap1 in these two conditions (Fig.
6o–s). These ﬁndings imply that Cadherin-5-mediated force
sensing/transmission is required for the nuclear localization of
Yap1. Another implication is that Yap1-dependent proliferation
is one mode by which tensile forces within endocardial tissue are
reduced during chamber expansion.
Discussion
Here, we used two different genetic conditions to model atrial
myocardial chamber expansion and to study the capability of the
endocardium to adapt to this enhanced myocardial growth. In
summary, our work suggests that some mode of intra-organ
communication between myocardium and endocardium serves to
coordinate the growth of different tissues of the heart during
cardiac ballooning. Our data suggests that the expansion of the
myocardial chambers is transmitted to the endocardium. As a
result, junctional forces rise within the endocardial tissue layer.
Here, we propose a model whereby these forces are transduced
via Cadherin-5 through the nuclear localization of Yap1, a tran-
scription factor that stimulates proliferative signaling (Fig. 7). The
means by which myocardial chamber expansion is communicated
between the two tissue layers is currently unknown but may
involve biomechanically active extracellular matrix components,
which are deposited within the tight space between endocardium
and myocardium2,3. Other means of intra-organ communication
are also possible which would result in increased tissue tension
within the endocardium. An alternative explanation might be that
the mechanical strain due to myocardial chamber expansion is
transmitted by cell junctional contacts between myocardial and
endocardial cells. Just as the adaptive growth of the endocardium
increases through an increase of these forces, it may end as a
result of the relaxation of tensile forces on the tissue. Conversely,
we also ﬁnd that smaller myocardial ventricular chamber
dimensions correspond with lower endocardial cell numbers. This
ﬁnding suggests that this mechanism not only impacts expanding
chambers but also holds true under physiological conditions of
the ventricle.
The developing heart experiences many other modes of intra-
organ communication based on chemical signaling2,3. How these
diverse modes of signaling are integrated at the cellular and tissue
levels remains to be addressed. The activation of proliferation
within the developing endocardium in response to changes in
chamber dimensions has important implications not only for our
understanding of heart morphogenesis during development but
also for characterizing patho-physiological conditions of the
heart. It will be of great interest to revisit endocardial chamber
development under conditions of congenital heart defects. The
present work provides a further component in this repertoire of
intra-organ communication, which causes biomechanical signal-
ing and tensile force-triggered proliferation within the endo-
cardium. This pattern may also hint at a general blueprint for the
coordination of growth rates in the tissues of other complex
organs; it shows that homeostatic responses which arise through
the morphological adaptations in size of one tissue likely coor-
dinate tissue-intrinsic growth rates within other tissues as well.
Methods
Zebraﬁsh handling and lines. Handling of zebraﬁsh was done in compliance with
German, Brandenburg and Lower Saxony state law, carefully monitored by the
local authority for animal protection (LAGV, Brandenburg and LANUV, Lower
Saxony). The following strains of zebraﬁsh were maintained under standard con-
ditions as previously described30: Tg(kdrl:EGFP)s84331, Tg(myl7:EGFP)twu34 32,
Tg(ﬂi1a:nEGFP)y7 33, Tg(ﬂt1:YFP)hu4624 15, Tg(hsp70l:Wnt8a-GFP)w34 34, Tg(act2:
myl12.1-EGFP)e2212 19, Tg(ﬂi1:EGFP-YAP)ncv35 27, nkx2.5vu179 12, and yap1fu4835.
Antisense oligonucleotide Morpholinos. Knock down studies were performed by
injection of the following antisense oligonucleotide morpholinos (MO) (Gene
Tools, LLC):
MO1-cadherin-525: 5′-TTTACAAGACCGTCTACCTTTCCAA-3′
yap1-ATG MO36: 5′-AGCAACATTAACAACTCACTTTAGG-3′
nkx2.5 ATG MO13: 5′-TCATTTGGCTAGAGAACATTGCCAT-3′
nkx2.7 ATG MO13: 5′-TGGAGGTCACAGGACTCGGAAGCAT-3′
A total of 1 nl MO solution was injected into one-cell-stage embryos at the
following concentration: 1 ng yap1MO, 0.5 ng cdh5MO, 4 ng nkx2.5MO, and 2 ng
nkx2.7 MO.
Transgenic overexpression via heat shock. For heat shock induced over-
expression of Tg(hspl70:Wnt8a-GFP)w34 up to 50 embryos were collected in a 2 ml
Eppendorf tube and pre-warmed egg water (38 °C) was added at 24 hpf. Embryos
were incubated at 38 °C for 45 min in a Thermomixer Comfort, which was turned
to the side while slowly shaking at 350 rpm. After heat shock, embryos were
transferred to Petri dishes ﬁlled with egg water and further incubated at 28.5 °C. At
30 hpf, GFP-positive embryos, carrying the transgenes, were selected and separated
from GFP-negative ﬁsh (used as controls) and further incubated until 52 hpf.
Direction of blood flow
Cardiac
ballooning 
Myocardial chamber expansion
Force transmission
within endocardium
Yap1
Cadherin-5
Proliferation
Fig. 7 Model of intra-organ communication within the developing zebraﬁsh
heart. Myocardial chamber expansion causes increased tensile forces
within the endocardial cell junctions which are transmitted by Cadherin-5.
This in tune causes the nuclear translocation of the Hippo signaling
transcription factor Yap1 activating cell proliferation within endocardial cells
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Immunohistochemistry. Embryos at the desired developmental stage were ﬁrst
anesthetized with 0.2% tricaine for one minute followed by ﬁxation with 4%
paraformaldehyde (PFA) for 1 h at room temperature. Fixed samples were washed
for 30 min with PBT which was followed by blocking with 10% NGS (Normal Goat
Serum) plus 2 mg per ml BSA and 0.8% Triton-X100 for 2 h at room temperature.
For immunolabeling of the cell surface marker Alcam or Yap1 blocking was per-
formed with PBDT (PBS 1× +0.1% v/v Tween 20+ 1% DMSO) supplemented
with 10% NGS. The primary antibody was incubated at 4 °C overnight in PBT
containing 0.8% Triton-X100. The following primary antibodies were used in this
study: anti-Islet1/2 (1:10; 39.4D5, Developmental Studies Hybridoma Bank), anti-
Islet1 (1:2000, Genetex, USA), anti-Alcam (1:100; zn-8, Developmental Studies
Hybridoma Bank), anti-Yap1 (1:200, generated in the Lecaudey lab), anti-GFP
(1:500, Aves labs, USA, #GFP-1020) and anti-atrial myosin heavy chain (1:10; S46,
Developmental Studies Hybridoma Bank). After incubation samples were washed
every 30 min for at least 2 h. This step was followed by secondary antibody incu-
bation overnight at 4 °C. The following secondary antibodies were used: Alexa
Fluor 647 goat anti-mouse IgG (1:250; Life Technologies), Alexa Fluor 647 goat
anti-rabbit IgG (1:250; Life Technologies), and goat anti-chicken FITC (1:250, Aves
labs, #F-1005). In addition, the following dyes were incubated in combination with
the secondary antibody: Alexa Fluor 546 Phalloidin (1:100, Invitrogen) and DAPI
(1:1000, Sigma). GFP protein within the transgenic reporter Tg(ﬂi1:EGFP-YAP)
ncv35 27 was visualized via an anti-GFP immunolabeling. Specimens were mounted
in PBT and imaged on Leica TCS SP8 confocal laser microscope.
EdU labeling and quantiﬁcation of cell proliferation. Myocardial or endocardial
proliferation in embryos expressing Tg(myl7:EGFP)twu34, Tg(kdrl:EGFP)s843, or Tg
(ﬂi1a:nEGFP)y7 was assessed using the Click-iT EdU Imaging Kit (Life Technol-
ogies) following the previous reported protocols37. Anaesthetized, dechorionated
embryos at 30 hpf were injected with 2 nl EdU solution (100 µM EdU, 2% DMSO,
0.1% phenol red) into the circulatory system. Incubation was performed until 52
hpf, afterwards embryos were rinsed with egg water and ﬁxed in 4% PFA over night
at 4 °C. In order to label the Tg(myl7:EGFP)twu34 and Tg(kdrl:EGFP)s843 or Tg(ﬂi1a:
nEGFP)y7 reporter lines a whole-mount immunostaining was performed using
chicken anti-GFP (1:500, Aves labs, USA, #GFP-1020) as the primary antibody and
goat anti-chicken FITC (1:250, Aves labs, #F-1005) as a secondary antibody. The
Click-iT reaction for EdU staining was performed by following the manufacturer’s
instructions. Images were acquired with a Leica TCS SP8 confocal laser microscope
using a 20× water-immersion objective. Quantiﬁcation of either proliferative
myocardial or endocardial cells was performed using Imaris (Bitplane, UK). Cells
were counted as proliferative when double labeled with GFP and EdU. The share of
EdU-positive cells was calculated as the percentage of proliferative cells among the
total number of myocardial or endocardial cells, respectively.
Multi-color mosaic-labeling. To label the myocardium in a mosaic color fashion
in vivo, myl7:TagRFP-T and myl7:TagBFP constructs were injected (kindly pro-
vided by D. Stainier)16 together with transposase mRNA into one cell stage
transgenic Tg(myl7:EGFP)twu34 or double transgenic Tg(hsp70l:Wnt8a-GFP)w34; Tg
(myl7:EGFP)twu34 embryos. After Tol2-mediated integration a clonal expression
pattern of the constructs was created and the myocardium was labeled with a
mixture of three ﬂuorescent proteins. For live high-resolution imaging individual
hearts of each condition with a colorful expression pattern were selected and
mounted in 1% low-melting agarose supplemented with 0.4 mg per ml Tricaine (3-
amino benzoic acidethylester; Sigma-Aldrich, A-5040) to stop the heartbeat while
the images were taken. An image stack was acquired on a confocal laser scanning
microscope Leica TCS SP8 with a ×20 objective every 30 min from 48–52 hpf with
optical sections at 1 µm thickness. Time lapse movies and images were analyzed
using Imaris Image Analysis Software (Bitplane, UK).
Microscopy and image analysis. Images were acquired using either a Leica SP8
confocal laser microscope or a Leica SP5 confocal laser microscope with ×20 or ×25
magniﬁcation for whole mount hearts, respectively. For ﬁxed samples, optical
sections with 1 µm z-steps were generated. For live-imaging, images were taken
every 30 min for up to 5 h with optical sections of 1 µm z-step thickness. Maximal
intensity projections were generated using the same settings for all samples. All
images were processed and analyzed using Fiji (NIH, USA) or Imaris (Bitplane,
UK). Brightness and contrast were adjusted with Imaris and Fiji.
Quantiﬁcations of Yap1-positive endocardial cell numbers. To quantify endo-
genous Yap1, endothelial/endocardial Tg(kdrl:EGFP)s843 or Tg(ﬂi1a:nEGFP)y7
reporter lines were immunolabeled and DAPI was used as a nuclear marker. Cells
doubly positive for nuclear Yap1 immunolabeling and an endothelial/endocardial
transgene were counted as a Yap1-positive endocardial cell. The share of Yap1-
positive cells was calculated as the percentage of Yap1-positive cells among the total
number of endocardial cells. Images were acquired on a Leica SP8 confocal laser
microscope and analyzed using Imaris (Bitplane, UK).
Quantiﬁcation of cell numbers and cell size measurements. Images were
acquired on a Leica SP8 confocal laser microscope and processed with Imaris
(Bitplane, UK). Maximal intensity projections were made to count the number of
myocardial or endocardial cells, respectively. To count myocardial cells, the
transgenic reporter Tg(myl7:GFP)twu34 or/and an immunohistochemistry staining
against Alcam was acquired. Since the reporter line labels myocardial nuclei, anti-
Alcam staining was performed to mark cell outlines. To count endocardial cells, the
transgenic reporter line Tg(kdrl:GFP)s843 or Tg(ﬂi1a:nEGFP)y7 was used. To spe-
ciﬁcally count cells within individual heart chambers, a counter staining of the
myocardial atrium was performed using anti-Myosin heavy chain 6 (Myh6)
immunolabeling.
Imaris was used to measure distances between two neighboring nuclei and at
least 20 different length measurements were performed per chamber. Myocardial
cell surface areas were quantiﬁed using Fiji (NIH, USA). Myocardial cell borders
were immunolabeled with anti-Alcam. Cell surroundings were measured in Fiji
using the free draw tool. Cell surface areas are displayed in μm2. For each heart at
least 15 cells were analyzed.
Zebraﬁsh endocardial tissue tension measurements. Endocardial tissue tension
was measured at 40 hpf using a UV-laser dissection set up as previously descri-
bed20. First, embryos were anesthetized with 0.2% Tricaine and mounted in 1%
agarose containing Tricaine to pause the heartbeat. Using a Zeiss 63 × 1.2 NA water
immersion lens, 4 μm long cuts were generated with 25 pulses of 1000 Hz.
Fluorescent images were acquired with a iXon DU-897-BV camera (Andor
Technology) using exposure times of 200 ms and a loop time of 200 ms. To ensure
comparability of the measurements, each heart was cut only once to avoid effects
on the entire heart due to the release of tissue tension and only cuts without any
immediate wound response were analyzed. For analysis, cells located within the
lower part of the endocardial inﬂow tract were targeted. Within each cell, a short
membrane compartment was cut which was oriented perpendicular to intra-
cardiac blood ﬂow or a long membrane compartment was cut oriented parallel to
blood ﬂow. Due to the ﬁndings that both membrane compartments show com-
parable initial recoil velocities, only the perpendicular membrane compartments
were selected for reliable comparability. Quantiﬁcation of the initial recoil velocity
upon junction dissection was performed as previously described using Fiji (NIH,
USA)38,39: A kymograph was generated to speciﬁcally display the myl12.1:eGFP
signal along the junction versus time and the opening slope was determined after
dissection. The tissue tension at endocardial cell junctions was calculated by linear-
regression analysis of the initial relaxation velocity. For statistical analysis PRISM
Graph Pad software was used.
Statistical analyses. If not stated otherwise, all experiments in this study were
performed in at least three independent biological replicates. Statistical analysis was
carried out using PRISM Graph Pad software. For comparison of two groups, that
were parametrically distributed, an unpaired two-tailed Student’s t-test was per-
formed. In order to compare more than two groups, a one-way ANOVA test and,
for two categorical independent variables, a two-way ANOVA was performed. A
p-value of ≤0.05 was considered signiﬁcant in all experiments (*p ≤ 0.05; **p ≤ 0.01;
***p ≤ 0.001; ****p ≤ 0.0001).
Reporting summary. Further information on research design is available in the
Nature Research Reporting Summary linked to this article.
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